team of British scientists from Imperial College London has been working on an experiment that, quite possibly, the most radically change the fate of the many millions of people suffering from various cardiovascular diseases.As informs on the pages an Internet portal medlinks.ru, the researchers were able to practice the revolutionary technology of using stem cells, which in the future will allow the most literal way to rejuvenate the heart, expanding its ability to pump blood.
In the course of their work by British scientists, led by Professor Schneider found a way to extract, to grow in the laboratory and then transplanted to the patient his own cells, which will eventually turn into a tissue of the heart muscle - the myocardium.This technology could eventually lead to a lack of need for transplantation of donor organs, which will save lives every year 238,000 residents of Albion, dying due to cardiovascular diseases.
also noted that new technology that was awarded for medical innovations of the futu
According to the president of the British Cardiovascular Society Dr. Nicholas Boone, who was one of the judges awarding prestigious medical award, the new technology will radically transform the treatment of patients after a heart attack or other diseases.In particular, in his speech professor said: "Since the therapies based on stem cells using the patient's own cells, it negates the risks or the likelihood of complications, which are usually associated with tissue rejection after transplantation."
As is known, cardiac arrest is accompanied by loss of heart muscle cells, and the currently available treatments do not allow them to recover.The most that can count the sick - so it is a relief to the symptoms of the disease through the use of various drugs.
As scientists from the National Heart and Lung Institute of the United Kingdom, they managed to find a way to rejuvenate the heart with the help of so-called prodzhenitornyh cells, which are precursors of cardiac tissue.These cells are located in the heart of every person, even though their number and very few (no more than 300 per million normal) - this fact one of the first leader of the study proved Professor Schneider, who heads the Division of Cardiology British Heart Foundation charity.And that this scientist is credited with creating the technology that enables clear prodzhenitornye cells from the patient's heart tissue cells for further growing them in the laboratory.
scientists tend to believe that the main purpose of prodzhenitornyh cells is to assist the heart in the process of recovery from everyday stress.Selecting said cells, scientists have been able to clone in the laboratory, and then multiply by a suitable nontoxic art.
As the results of experiments on mice, the cells give rise to cardiac muscle tissue.Currently, Professor Schneider is planning to carry out experiments on pigs, whose anatomy is known to be quite close to human anatomy."After about three years, we could conduct clinical trials on humans.It may be that patients with heart disease reversed, as they will grow healthy tissue, "- concludes the British scientist.
«This will be the biggest breakthrough in the treatment of heart disease" - described by British scientists achievement award founder of The Medical Futures Innovation Award Andy Goldberg, according to which, the practical results of the study can be expected in the very near future.